» Articles » PMID: 29623912

Cerebral Ischemia and Neuroregeneration

Overview
Date 2018 Apr 7
PMID 29623912
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral ischemia is one of the leading causes of morbidity and mortality worldwide. Although stroke (a form of cerebral ischemia)-related costs are expected to reach 240.67 billion dollars by 2030, options for treatment against cerebral ischemia/stroke are limited. All therapies except anti-thrombolytics (i.e., tissue plasminogen activator) and hypothermia have failed to reduce neuronal injury, neurological deficits, and mortality rates following cerebral ischemia, which suggests that development of novel therapies against stroke/cerebral ischemia are urgently needed. Here, we discuss the possible mechanism(s) underlying cerebral ischemia-induced brain injury, as well as current and future novel therapies (i.e., growth factors, nicotinamide adenine dinucleotide, melatonin, resveratrol, protein kinase C isozymes, pifithrin, hypothermia, fatty acids, sympathoplegic drugs, and stem cells) as it relates to cerebral ischemia.

Citing Articles

Altered Pattern of Serum N-Glycome in Subarachnoid Hemorrhage and Cerebral Vasospasm.

Czabajszki M, Garami A, Molnar T, Csecsei P, Viskolcz B, Olah C J Clin Med. 2025; 14(2).

PMID: 39860471 PMC: 11765641. DOI: 10.3390/jcm14020465.


mir-330-5p from mesenchymal stem cell-derived exosomes targets SETD7 to reduce inflammation in rats with cerebral ischemia-reperfusion injury.

Liu W, Shen Y, Pan R, Qi X J Mol Histol. 2024; 56(1):63.

PMID: 39738925 DOI: 10.1007/s10735-024-10347-6.


Localized molecular chaperone synthesis maintains neuronal dendrite proteostasis.

Alecki C, Rizwan J, Le P, Jacob-Tomas S, Comaduran M, Verbrugghe M Nat Commun. 2024; 15(1):10796.

PMID: 39737952 PMC: 11685665. DOI: 10.1038/s41467-024-55055-7.


Peroxisome and pexophagy in neurological diseases.

Xu W, Yan J, Shao A, Lenahan C, Gao L, Wu H Fundam Res. 2024; 4(6):1389-1397.

PMID: 39734532 PMC: 11670711. DOI: 10.1016/j.fmre.2023.04.016.


Targeting Neurological Disorders with Stilbenes: Bridging the Preclinical-Clinical Gap.

Begh M, Khan J, Zehravi M, Sweilam S, Raja A, Muthukumar A Int J Biol Sci. 2024; 20(14):5474-5494.

PMID: 39494329 PMC: 11528462. DOI: 10.7150/ijbs.102032.


References
1.
Song M, Mohamad O, Gu X, Wei L, Yu S . Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice. Cell Transplant. 2012; 22(11):2001-15. DOI: 10.3727/096368912X657909. View

2.
Kim J, Choi K, Jang Y, Bae S, Shin B, Choi B . Electroacupuncture acutely improves cerebral blood flow and attenuates moderate ischemic injury via an endothelial mechanism in mice. PLoS One. 2013; 8(2):e56736. PMC: 3572074. DOI: 10.1371/journal.pone.0056736. View

3.
Tedesco Triccas L, Burridge J, Hughes A, Verheyden G, Desikan M, Rothwell J . A double-blinded randomised controlled trial exploring the effect of anodal transcranial direct current stimulation and uni-lateral robot therapy for the impaired upper limb in sub-acute and chronic stroke. NeuroRehabilitation. 2015; 37(2):181-91. DOI: 10.3233/NRE-151251. View

4.
Pozo D, Reiter R, Calvo J, Guerrero J . Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci. 1994; 55(24):PL455-60. DOI: 10.1016/0024-3205(94)00532-x. View

5.
Olmez I, Ozyurt H . Reactive oxygen species and ischemic cerebrovascular disease. Neurochem Int. 2011; 60(2):208-12. DOI: 10.1016/j.neuint.2011.11.009. View